Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
PHR Analyst Ratings
Strong Buy
11 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PHR Stock 12 Month Forecast
Average Price Target
$34.89
▲(24.03% Upside)
| Highest Price Target$38.00 | Average Price Target$34.89 | Lowest Price Target$33.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TR | OpenAI - 4o
$34→$31
Hold
10.20%
Upside
Downgraded
09/06/25
Raymond James
$30→$33
Buy
17.31%
Upside
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy RatingWe reiterate our Outperform rating and increase our price target to $33 (+$3) on shares of PHR following a modest beat in F2Q26, as the company reported revenue of $117.3M (Street: $116.5M, $116.3M) with strength across network solutions (+24.7% y/y), subscription (+10.5%) and payments (+12.2%). Adj. EBITDA of $22.1M was slightly above expectations (Street: $20.0M, $20.5M) benefiting from lower-than-expected S&M expense ($25.4M vs. $30.4M) and G&A ($19.0M vs. $19.4M), partially offset by higher R&D investment ($29.3M vs. $28.2M). Management reiterated its FY26 revenue outlook of $472–482M and raised its adj. EBITDA guide to $87–92M ($2M midpoint increase) reflecting continued operating leverage.
William Blair
―
Buy
―
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Acquisitions Justify Buy RatingWe believe investors may focus on the incremental integration risk and complexity associated with the deal, given the story to this point has largely been oriented around strong organic growth. And while we view second- quarter results as solid, we also believe investors may be somewhat disappointed that the $2 million EBITDA guidance raise largely reflects the size of the beat in the period, given the strong operating leverage the model has shown in recent periods.
Needham
$35
Buy
24.42%
Upside
Reiterated
09/05/25
D.A. Davidson
$33
Buy
17.31%
Upside
Initiated
09/05/25
Piper Sandler
$33→$34
Buy
20.87%
Upside
Reiterated
09/05/25
Truist Financial
$35→$36
Buy
27.98%
Upside
Reiterated
09/05/25
Canaccord Genuity
$34→$38
Buy
35.09%
Upside
Reiterated
09/04/25
Citi
$34
Buy
20.87%
Upside
Reiterated
09/04/25
Mizuho Securities
$36
Buy
27.98%
Upside
Initiated
08/27/25
KeyBanc
$35
Buy
24.42%
Upside
Reiterated
08/22/25
J.P. Morgan
―
Buy
―
Reiterated
06/25/25
Robert W. Baird
$34→$31
Buy
10.20%
Upside
Reiterated
04/08/25
Jefferies
$32
Buy
13.76%
Upside
Reiterated
03/25/25
Citizens JMP
$30
Buy
6.65%
Upside
Reiterated
03/13/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TR | OpenAI - 4o
$34→$31
Hold
10.20%
Upside
Downgraded
09/06/25
Raymond James
$30→$33
Buy
17.31%
Upside
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Growth Initiatives Drive Buy RatingWe reiterate our Outperform rating and increase our price target to $33 (+$3) on shares of PHR following a modest beat in F2Q26, as the company reported revenue of $117.3M (Street: $116.5M, $116.3M) with strength across network solutions (+24.7% y/y), subscription (+10.5%) and payments (+12.2%). Adj. EBITDA of $22.1M was slightly above expectations (Street: $20.0M, $20.5M) benefiting from lower-than-expected S&M expense ($25.4M vs. $30.4M) and G&A ($19.0M vs. $19.4M), partially offset by higher R&D investment ($29.3M vs. $28.2M). Management reiterated its FY26 revenue outlook of $472–482M and raised its adj. EBITDA guide to $87–92M ($2M midpoint increase) reflecting continued operating leverage.
William Blair
―
Buy
―
Reiterated
09/05/25
Phreesia's Strong Financial Performance and Strategic Acquisitions Justify Buy RatingWe believe investors may focus on the incremental integration risk and complexity associated with the deal, given the story to this point has largely been oriented around strong organic growth. And while we view second- quarter results as solid, we also believe investors may be somewhat disappointed that the $2 million EBITDA guidance raise largely reflects the size of the beat in the period, given the strong operating leverage the model has shown in recent periods.
Needham
$35
Buy
24.42%
Upside
Reiterated
09/05/25
D.A. Davidson
$33
Buy
17.31%
Upside
Initiated
09/05/25
Piper Sandler
$33→$34
Buy
20.87%
Upside
Reiterated
09/05/25
Truist Financial
$35→$36
Buy
27.98%
Upside
Reiterated
09/05/25
Canaccord Genuity
$34→$38
Buy
35.09%
Upside
Reiterated
09/04/25
Citi
$34
Buy
20.87%
Upside
Reiterated
09/04/25
Mizuho Securities
$36
Buy
27.98%
Upside
Initiated
08/27/25
KeyBanc
$35
Buy
24.42%
Upside
Reiterated
08/22/25
J.P. Morgan
―
Buy
―
Reiterated
06/25/25
Robert W. Baird
$34→$31
Buy
10.20%
Upside
Reiterated
04/08/25
Jefferies
$32
Buy
13.76%
Upside
Reiterated
03/25/25
Citizens JMP
$30
Buy
6.65%
Upside
Reiterated
03/13/25
Best Analysts Covering Phreesia
1 Month
xxx
Success Rate
9/13 ratings generated profit
Average Return
+7.95%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 69.23% of your transactions generating a profit, with an average return of +7.95% per trade.
3 Months
xxx
Success Rate
9/14 ratings generated profit
Average Return
+9.38%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +9.38% per trade.
1 Year
Success Rate
13/13 ratings generated profit
Average Return
+26.32%
reiterated a buy rating 2 days ago
Copying Jailendra Singh's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +26.32% per trade.
2 Years
xxx
Success Rate
13/13 ratings generated profit
Average Return
+38.11%
reiterated a xxx
rating 2 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +38.11% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PHR Analyst Recommendation Trends
Rating
May 25
Jun 25
Jul 25
Aug 25
Sep 25
Strong Buy
1
0
0
0
0
Buy
28
16
15
10
16
Hold
12
8
7
4
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
41
24
22
14
19
Each month's total comprises the sum of three months' worth of ratings.
PHR Financial Forecast
PHR Stock Forecast FAQ
What is PHR’s average 12-month price target, according to analysts?
Based on analyst ratings, Phreesia’s 12-month average price target is 34.89.
What is PHR’s upside potential, based on the analysts’ average price target?
Phreesia has 24.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is PHR a Buy, Sell or Hold?
Phreesia has a consensus rating of Strong Buy which is based on 11 buy ratings, 0 hold ratings and 0 sell ratings.
What is Phreesia’s price target?
The average price target for Phreesia is 34.89. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $38.00 ,the lowest forecast is $33.00. The average price target represents 24.03% Increase from the current price of $28.13.
The highest analyst price target is $38.00 ,the lowest forecast is $33.00. The average price target represents 24.03% Increase from the current price of $28.13.
What do analysts say about Phreesia?
Phreesia’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
How can I buy shares of PHR?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.